FDA Clearance Tracker · P230017-S010
PulseSelect Pulse Field Ablation (PFA) Catheter
Last checked: Nov 20, 2026Latest source record: Apr 13, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Apr 13, 2026
Approved
Time to decision
34 days
Received Mar 10, 2026. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P230017-S010
- Device name
- PulseSelect Pulse Field Ablation (PFA) Catheter
- Applicant
- Medtronic, Inc.
- Applicant location
- Mounds View, MN
- Received
- Mar 10, 2026
- Decided
- Apr 13, 2026
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P230017
Device type
- Device class
- Class III
- Specialty
- CardiologyElectrophysiology
FDA's approval statement
As written in FDA's record.
approval for a manufacturing site located at Parkmore Business Park, West, Ballybrit, Galway, Ireland
Source documents
Other decisions for Medtronic, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K263596 · Decided Oct 29, 2026 · 29 days after receipt
Device type: Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass (DWF) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.